Seshadri Neervannan, Chief Operating Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 1,141 shares at $12.64 ($14K) on 2023-03-22, disclosed to the SEC on 2023-03-23.
Open-market sale of $14k TARS by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.89 | 372 | $5K | 33.5% |
| 2 | $12.64 | 379 | $5K | 33.4% |
| 3 | $12.15 | 390 | $5K | 33.1% |
| Total | $12.55 avg | 1,141 | $14K | 100% |
| Filing → |
| TARS | SELL | 2026-03-19 | $772K | — | Filing → |
| TARS | SELL | 2026-03-05 | $641K | — | Filing → |
| TARS | SELL | 2025-03-20 | $726K | — | Filing → |